How early-stage cells evade the immune system
Share on PinterestDesigned by MNT. Photography: sanjeri/Getty Images & CHRISTOPH BURGSTEDT/SCIENCE PHOTO LIBRARY/Getty Images Researchers report that some early-stage cancer cells activate genes that help them hide from the body’s immune response. They say identifying this increase in gene expression in cancer cells could lead to new pathways for early diagnosis and future treatment of […]
Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)…15 hours ago
Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)…15 hours ago